CD47 and central nervous system cancer: Consistently, human GBM (Figure 1E), including GSC7‐11 and GSC6‐27 primary GBM cells, or mouse glioma (Figure S1C, Supporting Information) cells, exhibited higher expression levels of CD47 than either normal human astrocytes (NHA) or mouse normal brain tissues, respectively.